Ffar2 expression regulates leukaemic cell growth in vivo

[1]  P. Sonveaux,et al.  Glutamine activates STAT3 to control cancer cell proliferation independently of glutamine metabolism , 2016, Oncogene.

[2]  Li‐Shu Wang,et al.  Loss of free fatty acid receptor 2 enhances colonic adenoma development and reduces the chemopreventive effects of black raspberries in ApcMin/+ mice , 2017, Carcinogenesis.

[3]  D. Munn,et al.  An essential role of Ffar2 (Gpr43) in dietary fibre-mediated promotion of healthy composition of gut microbiota and suppression of intestinal carcinogenesis , 2016, Oncogenesis.

[4]  R. Paquette,et al.  Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia , 2016, Oncotarget.

[5]  I. Martínez,et al.  Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia , 2015, The ISME Journal.

[6]  Ellen E. Blaak,et al.  Short-chain fatty acids in control of body weight and insulin sensitivity , 2015, Nature Reviews Endocrinology.

[7]  J. L. Ding,et al.  The short-chain fatty acid receptor GPR43 is transcriptionally regulated by XBP1 in human monocytes , 2015, Scientific Reports.

[8]  G. Ning,et al.  Free fatty acid receptor 2, a candidate target for type 1 diabetes, induces cell apoptosis through ERK signaling. , 2014, Journal of molecular endocrinology.

[9]  N. Delzenne,et al.  GPR43/FFA2: physiopathological relevance and therapeutic prospects. , 2013, TIPS - Trends in Pharmacological Sciences.

[10]  O. Feron,et al.  Gut microbiota-derived propionate reduces cancer cell proliferation in the liver , 2012, British Journal of Cancer.

[11]  L. Deldicque,et al.  Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. , 2011, The Journal of nutritional biochemistry.

[12]  D. Nie,et al.  G‐protein‐coupled receptor for short‐chain fatty acids suppresses colon cancer , 2011, International journal of cancer.

[13]  S. Wong,et al.  The first synthetic agonists of FFA2: Discovery and SAR of phenylacetamides as allosteric modulators. , 2010, Bioorganic & medicinal chemistry letters.

[14]  B. Druker,et al.  Translation of the Philadelphia chromosome into therapy for CML. , 2008, Blood.

[15]  C. Charrier,et al.  Synthesis of rigid trichostatin A analogs as HDAC inhibitors. , 2006, Bioorganic & medicinal chemistry letters.

[16]  T. Yokota,et al.  LSSIG is a novel murine leukocyte-specific GPCR that is induced by the activation of STAT3. , 2003, Blood.